Spearman's rank-correlation coefficients (r s ) were used to evaluate procedural complexity in relation to tenting area (r s , 0.833) and leaflet bending (r s , −0.821) (P<0.05 for both comparisons) (Panel A). Both tenting (bordered by leaflets and the plane of the annulus) and leaflet bending (the angle between the proximal and distal anterior leaflet) were measured in a long-axis view. A circle indicates simple-ring annuloplasty, an x additional subvalvular repair, and a plus sign anterior-leaflet augmentation combined with simple-ring annuloplasty and subvalvular repair. Kaplan-Meier estimates are shown (Panel B). MR denotes mitral regurgitation.
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To the Editor: Acker et al. report no significant difference between mitral-valve annuloplasty and replacement regarding left ventricular reverse remodeling and 12-month survival in patients with severe ischemic mitral regurgitation, which was defined as an effective regurgitant orifice of more than 40 mm 2 . However, because of the often hemielliptical shape of the mitral-regurgitation convergence zone, its use may lead to underestimation of the severity of mitral regurgitation. Severe ischemic mitral regurgitation should be considered when the effective regurgitant orifice is greater than 20 mm 2 . Consequently, a large number of patients probably had massive mitral regurgitation, limiting the potential effects of mitral-valve annuloplasty. When the effective regurgitant orifice was not quantifiable, severe mitral regurgitation was defined according to an integrative approach that included the ratio of jet area to the left atrial area, which is no longer recommended, 1 or an approach that relied on vena contracta jet width without a specified cutoff value. The authors do not mention the extent of the undersizing (i.e., one or two sizes) when they describe the mitral-valve annuloplasty procedure. Furthermore, to be effective, annuloplasty should target a leaflet-coaptation width of 8 mm or more. 2 Although mitral-valve annuloplasty is not necessarily the best possible surgical approach for patients with ischemic mitral regurgitation, the results of the present study need to be interpreted carefully. 
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To the Editor: Acker et al., reporting for the Cardiothoracic Surgical Trials Network, describe the results of a multicenter, randomized trial to evaluate the relative benefits and risks of valve repair versus replacement in patients with severe ischemic mitral regurgitation. No significant difference between the treatment groups was observed in left ventricular volume or survival at 12 months. However, whereas significant recurrent ischemic mitral regurgitation developed in more than 30% of the patients in the repair group, the patients in this group who did not have recurrent ischemic mitral regurgitation realized a 22.6% reduction in left ventricular volume versus a 6.8% reduction in the valve-replacement group. These data suggest a large potential benefit of valve repair if the effects of recurrent ischemic mitral regurgitation can be limited. The maturation of percutaneous valve-replacement technology that has occurred since the study's inception offers the potential for a new therapeutic model for these high-risk patients: all such patients should receive surgical annuloplasty, with recurrent ischemic mitral regurgitation treated with percutaneous valve-in-ring procedures. 1-3 This clinical strategy would maximize the beneficial effects of repair, eliminate the early morbidity associated with replacement, and neutralize the effects of recurrent ischemic mitral regurgitation. Robert C. Gorman, M.D.
